Zimmer Biomet
819 hedge funds and large institutions have $22.5B invested in Zimmer Biomet in 2017 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 265 increasing their positions, 291 reducing their positions, and 60 closing their positions.
161% more call options, than puts
Call options by funds: $212M | Put options by funds: $81.3M
12% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 60
10% more funds holding in top 10
Funds holding in top 10: 21 → 23 (+2)
7% more capital invested
Capital invested by funds: $21B → $22.5B (+$1.55B)
1.59% more ownership
Funds ownership: 87.96% → 89.54% (+1.6%)
0% more funds holding
Funds holding: 817 → 819 (+2)
9% less repeat investments, than reductions
Existing positions increased: 265 | Existing positions reduced: 291
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP
Jana Partners
New York
|
+$390M |
| 2 |
JP Morgan Chase
New York
|
+$195M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$105M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$87M |
| 5 |
BlackRock
New York
|
+$82.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
-$195M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$163M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$80.2M |
| 4 |
D.E. Shaw & Co
New York
|
-$76.9M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$64.5M |
ZBH Hedge Fund Activity: Q2 2017 in Review
819 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q2 2017, worth a combined $22.5B — up 7.4% from $21B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new ZBH positions and 60 closed out — a net gain of 7 holders — while 265 added to existing stakes and 291 trimmed.
The largest buyer was Jana Partners, opening a new position worth an estimated $390M. The largest seller was First Manhattan, cutting an estimated $195M.
- 819 institutional investors held Zimmer Biomet (ZBH) as of Q2 2017, up from 817 in Q1 2017.
- Funds reported $22.5B of Zimmer Biomet stock for Q2 2017, up 7.4% quarter-over-quarter.
- 67 funds opened new Zimmer Biomet positions in Q2 2017 and 60 closed out, a net change of +7 holders.
- The largest Zimmer Biomet buyer in Q2 2017 was Jana Partners, an estimated $390M added.
- The largest Zimmer Biomet seller in Q2 2017 was First Manhattan, an estimated $195M sold.
Based on aggregated 13F filings for Q2 2017.